Remifentanil Hydrochloride Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL REMIFENTANIL HYDROCHLORIDE INDUSTRY

2.1 Summary about Remifentanil Hydrochloride Industry

2.2 Remifentanil Hydrochloride Market Trends

2.2.1 Remifentanil Hydrochloride Production & Consumption Trends

2.2.2 Remifentanil Hydrochloride Demand Structure Trends

2.3 Remifentanil Hydrochloride Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1   1mg/Pcs

4.2.2 2mg/Pcs

4.2.3 5mg/Pcs

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Endotracheal intubation operation

4.3.2 Neurosurgery

4.3.3 Outpatient surgery

4.3.4 Postoperative analgesia

4.3.5 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1   1mg/Pcs

5.2.2 2mg/Pcs

5.2.3 5mg/Pcs

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Endotracheal intubation operation

5.3.2 Neurosurgery

5.3.3 Outpatient surgery

5.3.4 Postoperative analgesia

5.3.5 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1   1mg/Pcs

6.2.2 2mg/Pcs

6.2.3 5mg/Pcs

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Endotracheal intubation operation

6.3.2 Neurosurgery

6.3.3 Outpatient surgery

6.3.4 Postoperative analgesia

6.3.5 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1   1mg/Pcs

7.2.2 2mg/Pcs

7.2.3 5mg/Pcs

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Endotracheal intubation operation

7.3.2 Neurosurgery

7.3.3 Outpatient surgery

7.3.4 Postoperative analgesia

7.3.5 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1   1mg/Pcs

8.2.2 2mg/Pcs

8.2.3 5mg/Pcs

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Endotracheal intubation operation

8.3.2 Neurosurgery

8.3.3 Outpatient surgery

8.3.4 Postoperative analgesia

8.3.5 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1   1mg/Pcs

9.2.2 2mg/Pcs

9.2.3 5mg/Pcs

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Endotracheal intubation operation

9.3.2 Neurosurgery

9.3.3 Outpatient surgery

9.3.4 Postoperative analgesia

9.3.5 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 GSK

10.1.2 Macfarlan Smith

10.1.3 Abbott

10.1.4 Mylan

10.1.5 Arevipharma

10.1.6 AMRI

10.2 Remifentanil Hydrochloride Sales Date of Major Players (2017-2020e)

10.2.1 GSK

10.2.2 Macfarlan Smith

10.2.3 Abbott

10.2.4 Mylan

10.2.5 Arevipharma

10.2.6 AMRI

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Remifentanil Hydrochloride Product Type Overview

Table Remifentanil Hydrochloride Product Type Market Share List

Table Remifentanil Hydrochloride Product Type of Major Players

Table Brief Introduction of GSK

Table Brief Introduction of Macfarlan Smith

Table Brief Introduction of Abbott

Table Brief Introduction of Mylan

Table Brief Introduction of Arevipharma

Table Brief Introduction of AMRI

Table Products & Services of GSK

Table Products & Services of Macfarlan Smith

Table Products & Services of Abbott

Table Products & Services of Mylan

Table Products & Services of Arevipharma

Table Products & Services of AMRI

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Remifentanil Hydrochloride Market Forecast (Million USD) by Region 2021f-2026f

Table Global Remifentanil Hydrochloride Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Remifentanil Hydrochloride Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Remifentanil Hydrochloride Market Forecast (Million USD) Share by Demand 2021f-2026f